News Asia Colour Measurement Expansion in Asia
Lovibond Tintometer, innovators in colour measurement, has expanded its activities in Asia by opening a dedicated office to service the region. The new facilities, situated in the China Life Tower in Beijing, will provide invaluable support in driving the Lovibond®
business and
marketing activities in the region. Ms Sunny Yuan has also joined the company to continue and develop the close working relationships with the current Lovibond®
local representation ensures the Lovibond®
Reseller infrastructure. Having team
has direct access to trained personnel in their own time zone and local language - an invaluable service especially when one considers the extensive training and knowledge the Lovibond® employees have in colour measurement.
“Sunny will play an important role in supporting our local team,” explained Marke Reid, Sales and Marketing Director.
“The decision to have our own regional presence enforces the company’s commitment to this region and the importance we place on activities there.”
Sunny Yuan graduated from Beijing Jiaotong University with a Major in Chemistry and specific interest in instrumental analysis and testing. Prior to joining Lovibond®
, Yuan spent many years as
Technical and Service Manager within the colour industry where she organised technical trainings and focused on colour testing methods and product service for the Chinese market.
TO FIND OUT MORE CIRCLE NO. 307 Fourth Tecan Symposium Enjoys Chinese Success
Tecan recently hosted the fourth annual Tecan Symposium, welcoming leading genomics, proteomics and biobanking experts from around the globe to discuss this year’s topic; Translational Medicine: From bench to bedside and back. Held outside of Europe for the first time, the 2011 Tecan Symposium was in Shanghai, China, reflecting Tecan’s strong commitment to the Asian market and the growing importance of China as a major centre for genomics and clinical research. The two-day event was divided into four topics – current trends in translational research, clinical aspects of translational medicine, the growing importance of biobanking and the impact of technology on translational science – and explored a wide range of current hot topics in this fast-growing area of life science research.
The high quality program for this year’s event was opened by Professor Huanming Yang, President of China’s very own ‘genome
factory’, the Beijing Genomics Institute (BGI). A succession of enlightening presentations then charted the contributions that genomics and, more recently, proteomics have played in enhancing our understanding of the world around us, and how these breakthroughs are being applied to global health issues.
The second day’s program concentrated on the technologies behind the science, looking at why ‘biobanks are more than just a place to store freezers,’ the huge tasks that face the exciting global initiatives now being undertaken and what we can learn from the mummified remains of our ancient past. Fittingly, the Symposium’s final presentation was by Dr Colin Campbell from the University of Edinburgh, who discussed an exciting collaborative project first conceived during a chance meeting at the very first Tecan Symposium in Zurich.
Alongside the scientific content, Tecan’s local representatives – Tecan (Shanghai) Trading
Schott and Xinkang Agree on Joint Venture in China
German technology group Schott and the Chinese company Zhejiang Xinkang Pharmaceutical Glass Co, Ltd have signed an agreement to establish a pharmaceutical packaging joint venture in China.
Schott will own the majority of shares of the new company that will supply the fast-growing Chinese pharmaceutical market with high-quality pharmaceutical packaging products made of glass. The closing of the joint venture is subject to customary closing conditions.
“With the formation of this joint venture between Schott and Xinkang, two strong partners are joining forces. By combining Xinkang’s knowledge of the local market with Schott’s technological expertise, we will be able to supply Chinese pharmaceutical companies with high-quality packaging products even more effectively in the future,” explained Professor Udo Ungeheuer, Chairman of the Board of Management of Schott AG.
Delegates at the Tecan Symposium 2011
Company Ltd – arranged a number of social events for delegates, including a river cruise to provide a more relaxed environment to discuss the day’s topics, and a visit to a traditional Chinese tea house to celebrate the rich cultural heritage of Shanghai itself. Overall, the Fourth Tecan Symposium was hailed a great success, once again highlighting the innovation-driven, customer-focused approach that has made Tecan a leading provider within the life sciences sector.
TO FIND OUT MORE CIRCLE NO. 308
AB Sciex Acquires Labindia’s Mass Spectrometry Division to Broaden Presence in India
AB Sciex has announced that it has acquired the mass spectrometry business of Labindia Instruments Pvt Ltd, a leading life science solutions service provider in India. This acquisition represents AB Sciex’s increasing investment in India, combining its global resources, world-class scientific expertise and product development leadership with well- established, local expertise and on-site support to advance science and respond to the growing needs of India’s scientific community.
Labindia’s mass spectrometry business has been serving Indian users of AB Sciex instrumentation for the past 15 years. The transition of this business, including customer relationships, personnel and application support facilities, to AB Sciex is a direct result of the successful track record that AB Sciex and Labindia have had as partners in India.
AB Sciex has been actively involved in applying the power of mass spectrometry to assist in efforts to protect the health and safety of India’s vast population. The Company announced last year that through its distribution relationship with Labindia, it supplied a food safety testing solution to six major laboratories under the pesticides monitoring network project by India’s government. This was part of a project with the Ministry of Agriculture to help reinforce new food safety standards through better monitoring for contamination.
“Expansion of AB Sciex ‘s commercial operations in India will strengthen our position and help us build on the success of Labindia’s mass spectrometry business as well as execute on our growth strategy,” said Umesh Pawa (pictured right), Managing Director, AB Sciex India. “By integrating
Indian sales, service and support functions into AB Sciex‘s global resources and operational excellence, we will simplify the process for customers to do business with AB Sciex and drive the highest standard of support, further enhancing customer satisfaction levels. We will now be able to engage in a new level of dialogue with Indian scientists, who are among the leaders pushing the limits to improve life in this region.”
AB Sciex and Labindia are working closely to ensure a smooth transition of Labindia’s former mass spectrometry-focused personnel, who will provide uninterrupted service and support during this changeover and continue to be the day-to-day contacts for Indian mass spectrometry customers. As part of AB Sciex, the team will continue to work from their current locations in India.
TO FIND OUT MORE CIRCLE NO. 310
With this joint venture, Schott will be strengthening its position in the important growth market of China and continuing its expansion in the emerging pharmaceutical markets.
Schott Pharmaceutical Systems already operates manufacturing facilities in Brazil, Russia and India. The joint enterprise will manufacture at both Schott’s existing site in Suzhou, Jiangsu Province and in Jinyun, Zhejiang Province.
TO FIND OUT MORE CIRCLE NO. 309
3
Send us your News stories... Email:
gwyneth@intlabmate.com Read all the latest News & Views, Articles and New Product Releases Online, visit:
www.labmate-online.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44
